Biomea Fusion financials
$1.26−2.33%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$12.8M | -$12.8M | -$11.7M | -$20.8M | -$21.3M | -$29.7M | -$30.1M | -$34.0M | -$38.9M | -$41.1M | -$37.3M | -$31.1M |
| Net income | -$8.3M | -$12.4M | $4.6M | -$16.4M | -$20.7M | -$29.3M | -$29.3M | -$32.8M | -$37.3M | -$39.1M | -$34.9M | -$28.4M |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-0.12 | $-0.17 | $0.06 | $-0.27 | $-0.51 | $-0.80 | $-0.81 | $-0.91 | $-1.03 | $-1.09 | $-0.97 | $-0.80 |
| EBITDA | -$12.7M | -$12.7M | -$11.7M | -$18.2M | -$20.8M | -$29.2M | -$29.6M | -$33.6M | -$38.5M | -$40.6M | -$37.3M | -$30.7M |
| Operating cash flow | -$10.0M | -$11.7M | -$13.9M | -$11.6M | -$19.2M | -$25.7M | -$30.0M | -$25.2M | -$32.6M | -$32.0M | -$22.8M | -$23.9M |
| Free cash flow | -$10.0M | -$11.7M | -$13.9M | -$11.6M | -$19.2M | -$25.7M | -$30.1M | -$25.4M | -$32.7M | -$32.1M | -$22.8M | -$23.9M |
| Diluted shares | 72.4M | 72.3M | 71.8M | 59.8M | 40.6M | 36.6M | 36.3M | 36.2M | 36.0M | 35.9M | 35.8M | 35.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $34.8M | $44.7M | $55.8M | $46.6M | $56.2M | $35.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $36.9M | $46.4M | $58.6M | $55.2M | $73.2M | $55.1M |
| Total liabilities | $24.7M | $27.7M | $29.0M | $39.6M | $45.7M | $26.3M |
| Shareholders' equity | $12.1M | $18.7M | $29.6M | $15.6M | $27.5M | $28.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology